Seeking Alpha

Catalyst Pharmaceutical Partners (CPRX -2.4%) says it's issued 6,666,667 shares of its...

Catalyst Pharmaceutical Partners (CPRX -2.4%) says it's issued 6,666,667 shares of its authorized but unissued common stock to BioMarin Pharmaceutical (BMRN +2.5%) upon the automatic conversion of a $5M loan that CPRX received from BMRN in October in connection with it's licensing of the North American rights to Firdapse. The shares were issued at a conversion price of $0.75 per share.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector